Sunday, September 12, 2010

9/13 TERMSC

     
    TERMSC    
   
[Stem cells from fatty tissue : A new resource for regenerative medicine?]
September 13, 2010 at 12:21 AM
 

[Stem cells from fatty tissue : A new resource for regenerative medicine?]

Chirurg. 2010 Sep;81(9):826-32

Authors: Kuhbier JW, Weyand B, Sorg H, Radtke C, Vogt PM, Reimers K

While stem cells derived from the bone marrow are well-known in clinical medicine, fatty tissue as a source of mesenchymal stem cells is still the subject of recent research. However, adipose-derived stem cells (ASC) are not only harvested less invasively, i.e. via minimally invasive liposuction, but also yield higher numbers of multipotent stem cells.Due to cell-cell interactions and also because of the very favorable secretion profile of growth factors and cytokines ASCs displayed an extraordinary regenerative potential in recent preclinical and clinical applications and achieved a significantly better healing in ischemic muscle, heart, and brain insults and in impaired wound healing. ASCs enhanced regeneration in skeletal tissues such as cartilage or bone. They also revealed immunomodulatory effects and improved the clinical status in immunological diseases.In conclusion ASCs are comparable to bone marrow-derived stem cells concerning possible applications in clinical medicine.

PMID: 20830547 [PubMed - in process]

   
   
Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery.
September 13, 2010 at 12:21 AM
 

Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery.

Adv Drug Deliv Rev. 2010 Sep 6;

Authors: Porada CD, Almeida-Porada G

Mesenchymal stem cells (MSCs) possess a set of several fairly unique properties which make them ideally suited both for cellular therapies/regenerative medicine, and as vehicles for gene and drug delivery. These include: 1) relative ease of isolation; 2) the ability to differentiate into a wide variety of seemingly functional cell types of both mesenchymal and non-mesenchymal origin; 3) the ability to be extensively expanded in culture without a loss of differentiative capacity; 4) they are not only hypoimmunogenic, but they produce immunosuppression upon transplantation; 5) their pronounced anti-inflammatory properties; and 6) their ability to home to damaged tissues, tumors, and metastases following in vivo administration. In this review, we summarize the latest research in the use of mesenchymal stem cells in regenerative medicine, as immunomodulatory/anti-inflammatory agents, and as vehicles for transferring both therapeutic genes in genetic disease and genes designed to destroy malignant cells.

PMID: 20828588 [PubMed - as supplied by publisher]

   
   
Introduction to Series on Mesenchymal Stromal (Stem) Cells-MSCs.
September 13, 2010 at 12:21 AM
 

Introduction to Series on Mesenchymal Stromal (Stem) Cells-MSCs.

Hum Gene Ther. 2010 Sep;21(9):1037-8

Authors: O'Brien T, Barry F

PMID: 20828294 [PubMed - in process]

   
   
Simulated microgravity maintains the undifferentiated state and enhances the neural repair potential of bone marrow stromal cells.
September 13, 2010 at 12:21 AM
 

Simulated microgravity maintains the undifferentiated state and enhances the neural repair potential of bone marrow stromal cells.

Stem Cells Dev. 2010 Sep 9;

Authors: Yuge L, Sasaki A, Kawahara Y, Wu S, Matsumoto M, Manabe T, Kajiume T, Takeda M, Magaki T, Takahashi T, Kurisu K, Matsumoto M

Recently, regenerative medicine with bone marrow stromal cells (BMSCs) has gained significant attention for the treatment of central nervous system diseases. Here, we investigated the activity of BMSCs under simulated microgravity conditions. Mouse BMSCs (mBMSCs) were isolated from C57BL/6 mice and harvested in 1G condition. Subjects were divided into four groups, cultured in 3D-clinostat (group CL) and 1G condition (group C) under growth medium and neural differentiation medium. After 7 days of culture, the mBMSCs were used for morphological analysis, RT-PCR, immunostaining analysis, and grafting. Neural-induced mBMSCs cultured under 1G conditions exhibited neural differentiation, whereas those cultured under simulated microgravity did not. Moreover, under simulated microgravity conditions, mBMSCs could be cultured in an undifferentiated state. Next, we intravenously injected cells into a mouse model of cerebral contusion. Graft mBMSCs cultured under simulated microgravity exhibited greater survival in the damaged region, and the motor function of the grafted mice improved significantly. mBMSCs cultured under simulated microgravity expressed CXCR4 on their cell membrane. Our study indicates that culturing cells under simulated microgravity enhances their survival rate by maintaining an undifferentiated state of cells, making this a potentially attractive method for culturing donor cells to be used in grafting.

PMID: 20828292 [PubMed - as supplied by publisher]

   
   
CIRM Salaries: More Than You Want to Know
September 12, 2010 at 8:59 PM
 
   
   
CSCR Reading List: Salaries at the California Stem Cell Agency
September 12, 2010 at 7:59 PM
 
   
     
 
This email was sent to regenmd@gmail.com.
Delivered by Feed My Inbox
230 Franklin Road Suite 814 Franklin, TN 37064
Account Login
Unsubscribe Here Feed My Inbox
 
     

No comments: